Interactive virtual reality emerges as a new tool for drug design against COVID-19

Bristol scientists have demonstrated a new virtual reality [VR] technique which should help in developing drugs against the SARS-CoV-2 virus – and enable researchers to share models and collaborate in new ways. The innovative tool, created by University of Bristol researchers, and published in the Journal of Chemical Information and Modeling, will help scientists around the world identify anti-viral drug leads more rapidly.

A cartoon showing iMD-VR being used to model how a viral protein binds to the SARS-CoV-2 main protease
A cartoon showing iMD-VR being used to model how a viral protein binds to the SARS-CoV-2 main protease

Interactive molecular dynamics in virtual reality (iMD-VR) is an effective tool for flexible substrate and inhibitor docking to the SARS-CoV-2 main protease’ by A Mulholland et al in the Journal of Chemical Information and Modeling

Leave a Reply

Your email address will not be published.